SCHEMBL24405807

SCHEMBL24405807

CCCOc1cc(C)c(-n2c(=O)n(C)c3ccccc32)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GABRP O00591 1/20 0.38
▸ GABRD O14764 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB1 P18505 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ GABRA2 P47869 1/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ GABRA4 P48169 1/20 0.38
▸ GABRE P78334 1/20 0.38
▸ GABRA6 Q16445 1/20 0.38
▸ GABRG1 Q8N1C3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21463394 0.77 CYP1A2 (0.42) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL24405588 0.71 CREBBP (0.41) NPC1RAB9AALDH1A1TSHRLMNA
SCHEMBL21463619 0.69 NR1H2 (0.36) SMN1; SMN2MEN1KMT2AALDH1A1GAA
SCHEMBL24405665 0.69 TP53 (0.53) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL24405723 0.69 GAA (0.39) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL23119712 0.68 GAA (0.40) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL24405634 0.68 ALDH1A1 (0.40) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL21474179 0.68 GAA (0.39) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL24405780 0.67 CYP1A2 (0.46) MEN1KMT2AGABRA5CYP1A2CYP3A4
SCHEMBL24405492 0.64 BRD9 (0.40) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
Send feedback